Cancer Research Annual Meeting 2010  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 6685, July 15, 2007. doi: 10.1158/0008-5472.CAN-07-0495
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Myers, J. S.
Right arrow Articles by Cortez, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Myers, J. S.
Right arrow Articles by Cortez, D.

Molecular Biology, Pathobiology, and Genetics

Cyclin-Dependent Kinase 2–Dependent Phosphorylation of ATRIP Regulates the G2-M Checkpoint Response to DNA Damage

Jeremy S. Myers1, Runxiang Zhao1, Xin Xu1, Amy-Joan L. Ham1,2 and David Cortez1

1 Department of Biochemistry and 2 Mass Spectrometry Research Center, Vanderbilt University, Nashville, Tennessee

Requests for reprints: David Cortez, Department of Biochemistry, Vanderbilt University, 613 Light Hall, 23rd Pierce Avenue, Nashville, TN 37232. Phone: 615-322-8547; Fax: 615-343-0704; E-mail: david.cortez{at}vanderbilt.edu.

The ATR-ATRIP kinase complex regulates cellular responses to DNA damage and replication stress. Mass spectrometry was used to identify phosphorylation sites on ATR and ATRIP to understand how the kinase complex is regulated by post-translational modifications. Two novel phosphorylation sites on ATRIP were identified, S224 and S239. Phosphopeptide-specific antibodies to S224 indicate that it is phosphorylated in a cell cycle–dependent manner. S224 matches a consensus site for cyclin-dependent kinase (CDK) phosphorylation and is phosphorylated by CDK2-cyclin A in vitro. S224 phosphorylation in cells is sensitive to CDK2 inhibitors. Mutation of S224 to alanine causes a defect in the ATR-ATRIP–dependent maintenance of the G2-M checkpoint to ionizing and UV radiation. Thus, ATRIP is a CDK2 substrate, and CDK2-dependent phosphorylation of S224 regulates the ability of ATR-ATRIP to promote cell cycle arrest in response to DNA damage. [Cancer Res 2007;67(14):6685–90]




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. A. Lovejoy, X. Xu, C. E. Bansbach, G. G. Glick, R. Zhao, F. Ye, B. M. Sirbu, L. C. Titus, Y. Shyr, and D. Cortez
Functional genomic screens identify CINP as a genome maintenance protein
PNAS, November 17, 2009; 106(46): 19304 - 19309.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Lin, J. Wu, H. Dong, D. Bouck, F.-Y. Zeng, and T. Chen
Cyclin-dependent Kinase 2 Negatively Regulates Human Pregnane X Receptor-mediated CYP3A4 Gene Expression in HepG2 Liver Carcinoma Cells
J. Biol. Chem., November 7, 2008; 283(45): 30650 - 30657.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
D. A. Mordes, G. G. Glick, R. Zhao, and D. Cortez
TopBP1 activates ATR through ATRIP and a PIKK regulatory domain
Genes & Dev., June 1, 2008; 22(11): 1478 - 1489.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.